Along this line of argumentation, intriguingly, even heterozygous Nr2f6+/− mice exhibited the same ability to delay tumor outgrowth of implanted B16-OVA and MC38 tumors as Nr2f6 knockout mice. Here, NR2F6 is linked to neoplasm.